Product Information
CHILDREN'S MAPAP 80 MG TAB CHW is a generic product labeled by Major Pharmaceuticals, priced at $0.0648 per EA under NDC 00904579146. Its NADAC has been published 670 times since Nov 28, 2013.
Strength
80 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904579146
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
12/6/2004
Price Statistics
The NADAC for CHILDREN'S MAPAP 80 MG TAB CHW has been published 670 times since Nov 28, 2013, and over the history we have for it it has risen 57.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0648 per EA |
|---|---|
| All-time high | $0.0665 (Apr 15, 2026) |
| All-time low | $0.0387 (May 15, 2019) |
| 52-week high | $0.0665 |
| 52-week low | $0.0646 |
| Median price | $0.0513 |
| Average price | $0.0538 |
| Largest weekly change | +32.5% (Mar 23, 2022) |
| Weeks tracked | 670 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILDREN'S MAPAP 80 MG TAB CHW?
The current National Average Drug Acquisition Cost (NADAC) for CHILDREN'S MAPAP 80 MG TAB CHW, manufactured by Major Pharmaceuticals, is $0.0648 per EA (NDC 00904579146), effective Sep 30, 2026.
How has the price of CHILDREN'S MAPAP 80 MG TAB CHW changed over time?
Over the history we have for it, the NADAC for CHILDREN'S MAPAP 80 MG TAB CHW has risen 57.2%. It has been tracked across 670 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHILDREN'S MAPAP 80 MG TAB CHW?
Since Nov 28, 2013, the NADAC for CHILDREN'S MAPAP 80 MG TAB CHW has ranged from a low of $0.0387 (May 15, 2019) to a high of $0.0665 (Apr 15, 2026), with a median of $0.0513 per EA.
Are there cheaper alternatives to CHILDREN'S MAPAP 80 MG TAB CHW?
No other NADAC-published product currently shares the active ingredient and strength of CHILDREN'S MAPAP 80 MG TAB CHW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHILDREN'S MAPAP 80 MG TAB CHW?
CHILDREN'S MAPAP 80 MG TAB CHW (NDC 00904579146) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.